| Net Cash Provided by (Used in) Operating Activities |
$1,402,386 |
USD |
-2466% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$0 |
USD |
-100% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$1,401,343 |
USD |
|
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
20,000,000,000 |
shares |
|
Q2 2025 |
Q2 2025 |
| Common Stock, Shares, Issued |
7,384,006 |
shares |
|
Q2 2025 |
Q2 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
|
Q2 2025 |
Q2 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$1,043 |
USD |
-400% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$1,679 |
USD |
-85% |
Q2 2025 |
Q2 2025 |
| Deferred Tax Assets, Valuation Allowance |
$2,817,448 |
USD |
19% |
Q4 2024 |
FY 2024 |
| Depreciation |
$9,363 |
USD |
0% |
Q1 2025 |
Q1 2025 |
| Property, Plant and Equipment, Gross |
$222,681 |
USD |
|
Q2 2025 |
Q2 2025 |
| Preferred Stock, Shares Issued |
500,000,000 |
shares |
|
Q2 2025 |
Q2 2025 |
| Preferred Stock, Shares Authorized |
500,000,000 |
shares |
|
Q2 2025 |
Q2 2025 |
| Additional Paid in Capital |
$2,307,511 |
USD |
|
Q2 2025 |
Q2 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
$0 |
USD |
|
Q4 2024 |
FY 2024 |
| Interest Expense |
$0 |
USD |
-100% |
Q2 2025 |
Q2 2025 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
|
Q2 2025 |
Q2 2025 |